Self-assembled spherical nanostructures
Nicola Armaroli and co-workers from CNR-ISOF, Bologna, Italy, and Davide Bonifazi and colleagues from the Università di Trieste, Italy, and the University of Namur, Belgium, have shown that π-conjugated molecules bearing complementary hydrogen bonding sites can self-organise into complex nanostructures, which resemble natural micellar systems.
Nature creates spectacular nanoarchitectures through specific supramolecular assemblies of various components. Complementary hydrogen bonds are often utilised, which leads to the optimization of solvophilic interactions.
The use of hydrogen bonding also enables the tuning of the size and shape of the nanoparticles. The complementary hydrogen bonds promote self-organisation of the nanoparticles into uniform aggregates, and also enable a morphological change to occur from nanoparticle to vesicles.
Armaroli has also shown that the nanoaggregation can be reversed with temperature, which suggests possible applications of these vesicles in molecular delivery.
‘The ultimate aim of this work is to create a library of nanoarchitectures, which may exhibit potential applications as drug carriers, in biological imaging and in optoelectronic devices,’ says Armaroli.
However, Armaroli acknowledges that one of the main challenges to overcome is to design nanostructures with the desired molecular functionality, without compromising key features such as chemical stability and photoluminescence.
Original publication: Nicola Armaroli et al., Chem. Commun. 2009.
Other news from the department science
These products might interest you
NANOPHOX CS by Sympatec
Particle size analysis in the nano range: Analyzing high concentrations with ease
Reliable results without time-consuming sample preparation
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
DynaPro Plate Reader III by Wyatt Technology
Screening of biopharmaceuticals and proteins with high-throughput dynamic light scattering (DLS)
Efficiently characterize your sample quality and stability from lead discovery to quality control
